Camp4 Therapeutics (CAMP) Cash from Investing Activities (2023 - 2025)
Camp4 Therapeutics (CAMP) reported Cash from Investing Activities of $36000.0 for Q3 2025, up 112.9% sequentially from -$279000.0 in Q1 2025.
Camp4 Therapeutics (CAMP) Cash from Investing Activities (2023 - 2025) Analysis & Trends
Camp4 Therapeutics (CAMP) has 3 years of Cash from Investing Activities data on file, last reported at $36000.0 in Q3 2025.
- For the quarter ending Q3 2025, Cash from Investing Activities changed N/A year-over-year to $36000.0; the trailing twelve-month figure through Mar 2026 stood at $36000.0 (up 105.11% YoY), and the FY2025 full-year result was -$243000.0, up 44.9% from the prior year.
- Cash from Investing Activities advanced to $36000.0 in Q3 2025, from -$279000.0 in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $36000.0 in Q3 2025 to a low of -$279000.0 in Q1 2025.
- A 3-year average of -$154500.0 and a median of -$203000.0 in 2023 frame the typical range for Cash from Investing Activities.
- Across the five-year window, Cash from Investing Activities slipped 8.23% in 2024 and tumbled 1760.0% in 2025, its largest moves.
- Tracing CAMP's Cash from Investing Activities over 3 years: stood at -$243000.0 in 2023, then slipped by 8.23% to -$263000.0 in 2024, then soared by 113.69% to $36000.0 in 2025.
- Business Quant data shows CAMP's Cash from Investing Activities at $36000.0 in Q3 2025, -$279000.0 in Q1 2025, and -$263000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | -45.51 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | -431.90 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -428.90 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 172.62 Mn |
| 10 | Camp4 Therapeutics | 195.78 Mn | 195.78 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 36,000.00 |
| Sep 30, 2025 | 36,000.00 |
| Mar 31, 2025 | -279,000.00 |
| Mar 31, 2025 | -279,000.00 |
| Dec 31, 2024 | -263,000.00 |
| Dec 31, 2024 | -263,000.00 |
| Jun 30, 2024 | -163,000.00 |
| Jun 30, 2024 | -163,000.00 |
| Mar 31, 2024 | -15,000.00 |
| Mar 31, 2024 | -15,000.00 |
| Dec 31, 2023 | -243,000.00 |
| Dec 31, 2023 | -243,000.00 |